Partner

Our strong network of partners

Physiogenex is a preclinical CRO providing original and benchmarked animal models of obesity/type 2 diabetes and related co-morbidities:

NASH, dyslipidemia, inflammation, fibrosis, diabetic nephropathy, neuropathy, HFpEF and atherosclerosis.

For 20 years, we have been evaluating the efficacy of its clients‘ drugs using gold-standard and radiotracer-based experiments in our validated preclinical models.

With a 97.5% customer satisfaction rate last year, our clients benefit from our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners.

Staburo offers advanced, high-quality data science services and programming for international pharmaceutical, CRO and biotech clients.

We are experts in data science, with services including: biostatistics and programming, translational medicine and biomarkers, data transparency and bioinformatics.

Working with leading pharma companies, we know how to successfully bring compounds to the patient and are a reliable and flexible partner for our clients.

More information: https://staburo.com/

FGK Clinical Research is a full-service CRO offering the full range of clinical development and consulting services throughout Europe. FGK has two subsidiaries: „FGK Pharmacovigilance“ and „FGK Representative Services.“

These allow us to offer our clients pharmacovigilance services, including QPPV and PSMF management, as well as legal representation for non-European clients conducting clinical trials or seeking marketing authorization within the EU/EEA.

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board


LET’S TALK SCIENCE
Lars Schlichting

Head of Business Development


LET’S TALK BUSINESS
CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.